Home > PE Ratio > SAKAR HEALTHCARE

SAKAR HEALTHCARE
PE (Price/Earnings) Ratio

The Current P/E Ratio of SAKAR HEALTHCARE is 50.70.

Share Price ₹289.8Dec 26,2024
Market Cap ₹628.9 Cr
Earnings-TTM₹12.4 CrTTM-Consolidated Results
Price/Earnings50.70xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results
SAKAR HEALTHCARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SAKAR HEALTHCARE is calculated as :

Current Market Cap [ ₹628.9 Cr] as on Dec 26,2024

(/) Earnings [ ₹12.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 50.70x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 50.70 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.

Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE


PE Ratio Performance Analysis for SAKAR HEALTHCARE

- SAKAR HEALTHCARE 's latest p/e ratio is 50.70x.

- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 27.63x.

- SAKAR HEALTHCARE 's operated at median p/e ratio of 16.54x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.

- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 7.77x.


How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SAKAR HEALTHCARE 12.4050.70628.9
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.67441,838.0
CIPLA LTD4,485.2226.81120,270.0
DR REDDYS LABORATORIES LTD5,406.8020.91113,077.0
ZYDUS LIFESCIENCES LTD4,298.9022.4696,553.2
DIVIS LABORATORIES LTD1,836.0085.03156,107.0
MANKIND PHARMA LTD2,124.8656.57120,212.0
TORRENT PHARMACEUTICALS LTD1,802.0064.17115,643.0
LUPIN LTD2,651.9437.5399,532.1
AUROBINDO PHARMA LTD3,598.8320.2772,945.8
ABBOTT INDIA LTD1,284.6647.3660,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.27x
Max industry PE 85.03x
Median industry PE 39.67x
Average industry PE 42.86x



You may also like the below Video Courses